MICROFABRICATED DEVICES: A SIGNIFICANT ADVANCE FOR THE DETECTION AND MOLECULAR ANALYSES OF CIRCULATING CANCER CELLS?
Funder
National Health and Medical Research Council
Funding Amount
$422,107.00
Summary
Using advanced microfabrication concepts, this project aims to develop a platform technology able to capture tumour cells circulating in the blood of cancer patients. Although present only in extremely small numbers, these cells provide invaluable insights into the pathophysiology of the disease and consequently provide vital diagnostic and prognostic information. Molecular analyses of these cancer cells could ultimately enable the design of improved and personalized cancer treatment.
Spectrometer Module For Surface Enhanced Raman Scattering Spectroscopy In Glucose Analysis
Funder
National Health and Medical Research Council
Funding Amount
$385,151.00
Summary
Scientists have developed a number of incredibly powerful and sophisticated techniques to identify chemicals and measure their concentrations in the laboratory. However, it remains a major challenge to perform these measurements under everyday circumstances. For example, surface-enhanced Raman scattering (SERS) has gained widespread recognition as a technique for trace chemical detection, but it remains confined to a small number of specialist laboratories. For this reason, Dr Paul Stoddart at S ....Scientists have developed a number of incredibly powerful and sophisticated techniques to identify chemicals and measure their concentrations in the laboratory. However, it remains a major challenge to perform these measurements under everyday circumstances. For example, surface-enhanced Raman scattering (SERS) has gained widespread recognition as a technique for trace chemical detection, but it remains confined to a small number of specialist laboratories. For this reason, Dr Paul Stoddart at Swinburne University of Technology recognised a need for more practical SERS probes for field applications. His team has now developed a proprietary SERS probe, based on an optical fibre that is little thicker than a hair. These optical fibres can form the core element of field-portable SERS spectrometers. This work has recently been boosted by the discovery in the United States that SERS can be used to monitor glucose in blood. The development of a continuous glucose monitor has long been a holy grail of sensor research, because of the millions of diabetes sufferers who regularly perform the painful finger prick test. For SERS to provide a practical solution to glucose monitoring, it is recognised that SERS optical fibres are needed for minimally invasive probes. With support from Biopharmica and the Diabetes Australia Research Trust, Dr Stoddart's team has now demonstrated that sensitive SERS probes can be produced in large quantities. The next objective is to develop a prototype low-cost SERS spectrometer for use as part of a continuous glucose monitoring system. This will require the development of a laser source and spectroscopic system that can interface to the SERS probes. It is proposed to use an Australian designed and manufactured laser system based on a low-power narrow-linewidth laser diode. The project plans to bring together Swinburne University, OptoTech and Grey Innovation in order to develop a commercially scaleable and robust device.Read moreRead less
Micropapillary Adenocarcinoma: The Emergence Of A Discrete Lung Cancer Phenotype And Its Genomic And Transcriptomic Characterization.
Funder
National Health and Medical Research Council
Funding Amount
$117,565.00
Summary
I believe I can describe a new subtype of lung cancer, which has never been classified by the World Health Organization. This has been previously mis-classified or simply ignored. My hypothesis is that this is a distinct disease by virtue of patterns of genetic abnormalities as well as features visible under the microscope. I also believe it is one of the most aggressive cancers and needs new treatments.
Biocompatible Gadolinium-free Contrast Agents For Molecular Targeted MR Imaging
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Building on the biomedical engineering of USPIOs, this project expects to generate new probing tools for non-invasive molecular imaging and affect subsequent clinical imaging through earlier and more accurate diagnosis of diseases. The project will allow the delivery of new knowledge in the emerging field of nanomedicine with high clinical translation potentials.
Rapid, Point Of Care Diagnostic Tests To Differentiate HA Subtypes In Patients Samples
Funder
National Health and Medical Research Council
Funding Amount
$168,293.00
Summary
A number of rapid, point-of-care tests are available for the detection of human and avian influenza types, but they vary greatly in sensitivity. In particular, these tests are based on current strains of H5 (avian) influenza, and may be unable to detect variant or pandemic strains, and negative results can give the false impression that patients do not have H5 influenza. We will develop rapid, point-of-care tests based on highly conserved parts of the virus, so that all H5 strains (current and f ....A number of rapid, point-of-care tests are available for the detection of human and avian influenza types, but they vary greatly in sensitivity. In particular, these tests are based on current strains of H5 (avian) influenza, and may be unable to detect variant or pandemic strains, and negative results can give the false impression that patients do not have H5 influenza. We will develop rapid, point-of-care tests based on highly conserved parts of the virus, so that all H5 strains (current and future) can be detected with equal sensitivity, along with the H1 and H3 strains that are currently found in man to provide a definitive diagnosis. These tests will be valuable in the identification and differentiation of pandemic influenza cases, allowing better use of public health resources, especially against a background of continuing standard (H1 and H3) influenza infections.Read moreRead less
Predicting Obstructive Sleep Apnoea Using 3D Craniofacial Photography
Funder
National Health and Medical Research Council
Funding Amount
$424,715.00
Summary
Sleep Apnoea is a common medical condition associated with snoring and collapse of the throat during sleep. Diagnosis of sleep apnoea involves an overnight sleep study in a specialised laboratory, which is expensive and time consuming. It is possible that sleep apnea could be diagnosed from a 3-dimensional photograph of the face. This study will define the relationships between sleep apnea and 3D face photographs in 956 young adults and 1,200 of their parents, and 3,000 sleep clinic patients.
In Vitro Diagnostic For First Trimester Risk Assignment Of Gestational Diabetes
Funder
National Health and Medical Research Council
Funding Amount
$580,983.00
Summary
Pregnancy associated diabetes is a significant complication of pregnancy that has adverse health effects for both mother and baby. We have developed a multivariate algorithm to identify women during their first trimester of pregnancy who will subsequently develop gestational diabetes. The test requires further clinical validation to develop a commercial product and to implement it into clinical practice.
Exploring The Occurrence And Potential Associated Risk Factors For Pilchard Orthomyxovirus (POMV) In Tasmanian Farmed Atlantic Salmon
Funder
Fisheries Research and Development Corporation
Funding Amount
$209,295.62
Summary
Following basic epidemiology principles, no infectious disease occurs ‘randomly’ and its occurrence follow logical and predictable patterns. The presence of an infectious agent is unlikely sufficient to explain these patterns and most aquatic diseases result from the complex interaction between the agent, the host and its environment. Therefore, the targeted outcome for a POMV control plan is threefold: 1. Decrease transmission between infected and susceptible fish groups – this requires ide ....Following basic epidemiology principles, no infectious disease occurs ‘randomly’ and its occurrence follow logical and predictable patterns. The presence of an infectious agent is unlikely sufficient to explain these patterns and most aquatic diseases result from the complex interaction between the agent, the host and its environment. Therefore, the targeted outcome for a POMV control plan is threefold: 1. Decrease transmission between infected and susceptible fish groups – this requires identifying risk factors associated with the introduction, spread, and maintenance of the pathogen within the industry; 2. Decrease the number of susceptible fish – this mainly requires identifying risk factors associated with the susceptibility of the host (e.g. husbandry-related stress) and the development of a safe and effective prophylaxis; 3. Decrease the amount of virus in the environment - this requires detecting infected fish cage(s) early to implement timely control strategies. Diagnostic capacity to confirmed POMV outbreak has been developed and is currently used in routine by the industry. A vaccine against POMV is currently under development at the Tasmanian Aquatic Animal Health and Vaccines Centre of Excellence and will be available in the future. However, little is known about risk factors specific to POMV and about its full economic impact. We define as a ‘risk factor’ any attribute of the agent, the host or its environment that increases the risk and intensity of a disease outbreak. Most of the environmental risk factors (including farming practices) facilitate the introduction, transmission, or maintenance of the pathogen; while the host risk factors affect the susceptibility of the host and its capacity to become diseased. Like the closely related ISAv, the magnitude and occurrence of POMV outbreaks appeared to be highly variable. This supports the existence of additional factors other than the POMV infection that contribute to the intensity of an outbreak. It is anticipated that by identifying and intervening on some of the manageable risk factors, the frequency and the severity of POMV outbreaks can be reduced. Objectives: 1. Describe the occurrence of POMV outbreaks in the Tasmanian salmon industry 2. Quantify the direct financial impact of POMV mortality to the Tasmanian salmon industry 3. Identify potential management, environmental and stock risk factors directly or indirectly increasing the risk and intensity of a POMV outbreaks Read moreRead less
Structural and pharmaceutical studies on a novel human protein, MIC-1. Cancer and obesity are two of the main health problems facing Australia, as reflected by the National Research Priority: Promoting and Maintaining Good Health. This project will develop new diagnostic tools for early cancer detection and prognosis using the protein, MIC-1. MIC-1 is responsible for cachexia, a wasting disorder responsible for 25% of cancer deaths, which has no effective therapy. MIC-1 and antibodies neutrali ....Structural and pharmaceutical studies on a novel human protein, MIC-1. Cancer and obesity are two of the main health problems facing Australia, as reflected by the National Research Priority: Promoting and Maintaining Good Health. This project will develop new diagnostic tools for early cancer detection and prognosis using the protein, MIC-1. MIC-1 is responsible for cachexia, a wasting disorder responsible for 25% of cancer deaths, which has no effective therapy. MIC-1 and antibodies neutralising MIC-1 may provide therapeutic agents to control cancer cachexia and severe obesity. The project will optimise these molecules for therapeutic uses. These diagnostic and therapeutic tools will form the basis of a spin-off company for commercialisation. Read moreRead less
Identification of novel markers of inflammation. This project will benefit Australia as it will increase basic understanding of inflammatory processes, result in a new generation of diagnostics for inflammatory diseases that could lead to earlier diagnosis and to monitor treatment, resulting in large economic and health benefit. It may lead to development of novel new therapies using monoclonal antibodies to regulate processes in immune, cardiovascular and infectious diseases. The work will gene ....Identification of novel markers of inflammation. This project will benefit Australia as it will increase basic understanding of inflammatory processes, result in a new generation of diagnostics for inflammatory diseases that could lead to earlier diagnosis and to monitor treatment, resulting in large economic and health benefit. It may lead to development of novel new therapies using monoclonal antibodies to regulate processes in immune, cardiovascular and infectious diseases. The work will generate significant economic spin-offs to the Australian biotechnology industry and will further relationships and training between research and development.Read moreRead less